ENDRA Life Sciences (NDRA) Return on Capital Employed Growth (3y) (2020 - 2026)
ENDRA Life Sciences (NDRA) Return on Capital Employed Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,149.49 Bn | 29,149.03 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 174.37 Bn | 171.12 Bn | 7.74 Bn | -80.00 |
| 3 | Danaher | 127.33 Bn | 121.64 Bn | 3.59 Bn | -312.00 |
| 4 | Idexx Laboratories | 44.68 Bn | 44.48 Bn | 722.74 Mn | 1,361.00 |
| 5 | Agilent Technologies | 36.54 Bn | 34.74 Bn | 990.00 Mn | -383.00 |
| 6 | Iqvia Holdings | 30.51 Bn | 28.53 Bn | 1.36 Bn | 84.00 |
| 7 | Natera | 30.00 Bn | 28.90 Bn | 696.04 Mn | 4,725.00 |
| 8 | Illumina | 24.61 Bn | 23.45 Bn | 721.00 Mn | 10,173.00 |
| 9 | Mettler Toledo International | 22.91 Bn | 22.85 Bn | 555.82 Mn | -363.00 |
| 10 | ENDRA Life Sciences | 5.52 Mn | 5.16 Mn | - | 13,834.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,834.00 |
| Dec 31, 2025 | 7,613.00 |
| Sep 30, 2025 | -42,560.00 |
| Jun 30, 2025 | -25,094.00 |
| Mar 31, 2025 | -18,122.00 |
| Dec 31, 2024 | -9,455.00 |
| Sep 30, 2024 | -2,015.00 |
| Jun 30, 2024 | -8,126.00 |
| Mar 31, 2024 | -13,689.00 |
| Dec 31, 2023 | 2,164.00 |
| Sep 30, 2023 | 25,833.00 |
| Jun 30, 2023 | 27,805.00 |
| Mar 31, 2023 | 4,838.00 |
| Dec 31, 2022 | 18,180.00 |
| Sep 30, 2022 | 52,056.00 |
| Dec 31, 2021 | 18,312.00 |
| Dec 31, 2020 | -11,160.00 |
| Sep 30, 2020 | -42,043.00 |
| Jun 30, 2020 | -43,474.00 |
| Mar 31, 2020 | -39,075.00 |